Do analysts recommend BLGO or ACNT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Ascent Industries 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer ARQ or BLGO?

ARQ currently has a consensus target price of $5.00, suggesting a potential upside of 116.45%. Given ARQ's stronger consensus rating and higher probable upside, equities analysts clearly believe ARQ is more favorable than BioLargo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ARQ 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, ARQ or BLGO?

BioLargo has lower revenue, but higher earnings than ARQ. BioLargo is trading at a lower price-to-earnings ratio than ARQ, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ARQ $120.34M 0.84 -$52.61M -$1.26 N/A BioLargo $12.23M 2.69 -$3.50M -$0.05 N/A

Is ARQ or BLGO more profitable?

BioLargo has a net margin of -11.45% compared to ARQ's net margin of -42.33%. ARQ's return on equity of -2.54% beat BioLargo's return on equity. Company Net Margins Return on Equity Return on Assets ARQ -42.33% -2.54% -1.88% BioLargo -11.45% -39.90% -22.06%

Do analysts recommend NTIC or BLGO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Northern Technologies International 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend BLGO or FSI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Flexible Solutions International 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00

Do analysts rate BLGO or AVD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

BioLargo (BLGO) Competitors

$0.10 0.00 (-3.75%)

As of 03:38 PM Eastern

Compare

BLGO vs. ACNT, ARQ, NTIC, FSI, and AVD

Should you buy BioLargo stock or one of its competitors? BioLargo's main competitors and comparable companies include Ascent Industries (ACNT), ARQ (ARQ), Northern Technologies International (NTIC), Flexible Solutions International (FSI), and American Vanguard (AVD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "chemicals" industry.

How does BioLargo compare to Ascent Industries?

BioLargo (NASDAQ:BLGO) and Ascent Industries (NASDAQ:ACNT) are both small-cap materials companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

BioLargo has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market. Comparatively, Ascent Industries has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

In the previous week, Ascent Industries had 2 more articles in the media than BioLargo. MarketBeat recorded 2 mentions for Ascent Industries and 0 mentions for BioLargo. Ascent Industries' average media sentiment score of 1.75 beat BioLargo's score of 0.00 indicating that Ascent Industries is being referred to more favorably in the news media.

Company	Overall Sentiment
BioLargo	Neutral
Ascent Industries	Very Positive

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 26.1% of Ascent Industries shares are owned by institutional investors. 19.3% of BioLargo shares are owned by insiders. Comparatively, 7.5% of Ascent Industries shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Ascent Industries	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ascent Industries has a net margin of -5.31% compared to BioLargo's net margin of -11.45%. Ascent Industries' return on equity of -2.72% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLargo	-11.45%	-39.90%	-22.06%
Ascent Industries	-5.31%	-2.72%	-2.07%

Ascent Industries has higher revenue and earnings than BioLargo. Ascent Industries is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23M	2.69	-$3.50M	-$0.05	N/A
Ascent Industries	$74.94M	1.82	$870K	-$0.45	N/A

Summary

Ascent Industries beats BioLargo on 10 of the 14 factors compared between the two stocks.

How does BioLargo compare to ARQ?

ARQ (NASDAQ:ARQ) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

ARQ currently has a consensus target price of $5.00, suggesting a potential upside of 116.45%. Given ARQ's stronger consensus rating and higher probable upside, equities analysts clearly believe ARQ is more favorable than BioLargo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ARQ	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

BioLargo has a net margin of -11.45% compared to ARQ's net margin of -42.33%. ARQ's return on equity of -2.54% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ARQ	-42.33%	-2.54%	-1.88%
BioLargo	-11.45%	-39.90%	-22.06%

18.5% of ARQ shares are owned by institutional investors. Comparatively, 0.0% of BioLargo shares are owned by institutional investors. 20.1% of ARQ shares are owned by insiders. Comparatively, 19.3% of BioLargo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

ARQ has a beta of 2.02, meaning that its stock price is 102% more volatile than the broader market. Comparatively, BioLargo has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market.

BioLargo has lower revenue, but higher earnings than ARQ. BioLargo is trading at a lower price-to-earnings ratio than ARQ, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ARQ	$120.34M	0.84	-$52.61M	-$1.26	N/A
BioLargo	$12.23M	2.69	-$3.50M	-$0.05	N/A

In the previous week, ARQ had 4 more articles in the media than BioLargo. MarketBeat recorded 4 mentions for ARQ and 0 mentions for BioLargo. BioLargo's average media sentiment score of 0.00 beat ARQ's score of -0.24 indicating that BioLargo is being referred to more favorably in the news media.

Company	Overall Sentiment
ARQ	Neutral
BioLargo	Neutral

Summary

ARQ beats BioLargo on 11 of the 16 factors compared between the two stocks.

How does BioLargo compare to Northern Technologies International?

Northern Technologies International (NASDAQ:NTIC) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

Northern Technologies International has higher revenue and earnings than BioLargo. Northern Technologies International is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Northern Technologies International	$84.24M	0.91	$20K	-$0.12	N/A
BioLargo	$12.23M	2.69	-$3.50M	-$0.05	N/A

Northern Technologies International has a net margin of -1.26% compared to BioLargo's net margin of -11.45%. Northern Technologies International's return on equity of -0.45% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Northern Technologies International	-1.26%	-0.45%	-0.33%
BioLargo	-11.45%	-39.90%	-22.06%

32.9% of Northern Technologies International shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 24.9% of Northern Technologies International shares are held by company insiders. Comparatively, 19.3% of BioLargo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Northern Technologies International has a beta of 0.17, suggesting that its stock price is 83% less volatile than the broader market. Comparatively, BioLargo has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Northern Technologies International	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Northern Technologies International had 1 more articles in the media than BioLargo. MarketBeat recorded 1 mentions for Northern Technologies International and 0 mentions for BioLargo. Northern Technologies International's average media sentiment score of 1.89 beat BioLargo's score of 0.00 indicating that Northern Technologies International is being referred to more favorably in the media.

Company	Overall Sentiment
Northern Technologies International	Very Positive
BioLargo	Neutral

Summary

Northern Technologies International beats BioLargo on 11 of the 14 factors compared between the two stocks.

How does BioLargo compare to Flexible Solutions International?

BioLargo (NASDAQ:BLGO) and Flexible Solutions International (NYSE:FSI) are both small-cap materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment.

0.0% of BioLargo shares are held by institutional investors. Comparatively, 54.3% of Flexible Solutions International shares are held by institutional investors. 19.3% of BioLargo shares are held by insiders. Comparatively, 35.8% of Flexible Solutions International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Flexible Solutions International had 6 more articles in the media than BioLargo. MarketBeat recorded 6 mentions for Flexible Solutions International and 0 mentions for BioLargo. Flexible Solutions International's average media sentiment score of 0.52 beat BioLargo's score of 0.00 indicating that Flexible Solutions International is being referred to more favorably in the news media.

Company	Overall Sentiment
BioLargo	Neutral
Flexible Solutions International	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Flexible Solutions International	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	3.00

Flexible Solutions International has higher revenue and earnings than BioLargo. Flexible Solutions International is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23M	2.69	-$3.50M	-$0.05	N/A
Flexible Solutions International	$39.34M	1.75	$2.78M	-$0.24	N/A

Flexible Solutions International has a net margin of 10.80% compared to BioLargo's net margin of -11.45%. Flexible Solutions International's return on equity of 10.61% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLargo	-11.45%	-39.90%	-22.06%
Flexible Solutions International	10.80%	10.61%	7.32%

BioLargo has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market. Comparatively, Flexible Solutions International has a beta of 1.66, suggesting that its share price is 66% more volatile than the broader market.

Summary

Flexible Solutions International beats BioLargo on 13 of the 15 factors compared between the two stocks.

How does BioLargo compare to American Vanguard?

BioLargo (NASDAQ:BLGO) and American Vanguard (NYSE:AVD) are both small-cap materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 79.0% of American Vanguard shares are owned by institutional investors. 19.3% of BioLargo shares are owned by company insiders. Comparatively, 5.6% of American Vanguard shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

American Vanguard has a net margin of -10.70% compared to BioLargo's net margin of -11.45%. American Vanguard's return on equity of -9.05% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLargo	-11.45%	-39.90%	-22.06%
American Vanguard	-10.70%	-9.05%	-2.78%

BioLargo has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market. Comparatively, American Vanguard has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

In the previous week, American Vanguard had 4 more articles in the media than BioLargo. MarketBeat recorded 4 mentions for American Vanguard and 0 mentions for BioLargo. BioLargo's average media sentiment score of 0.00 beat American Vanguard's score of -0.37 indicating that BioLargo is being referred to more favorably in the media.

Company	Overall Sentiment
BioLargo	Neutral
American Vanguard	Neutral

BioLargo has higher earnings, but lower revenue than American Vanguard. BioLargo is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23M	2.69	-$3.50M	-$0.05	N/A
American Vanguard	$515.11M	0.13	-$49.88M	-$1.90	N/A

Summary

American Vanguard beats BioLargo on 9 of the 14 factors compared between the two stocks.

Get BioLargo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BLGO vs. The Competition

Export

Metric	BioLargo	Chemicals Industry	Materials Sector	NASDAQ Exchange
Market Cap	$34.13M	$11.52B	$4.86B	$13.06B
Dividend Yield	N/A	2.85%	4.71%	10.62%
P/E Ratio	-10.01	42.10	25.28	25.39
Price / Sales	2.69	52.06	4,718.52	88.46
Price / Cash	N/A	15.51	24.65	38.47
Price / Book	10.01	3.58	8.86	6.51
Net Income	-$3.50M	$222.46M	$154.79M	$347.22M
7 Day Performance	-5.57%	-0.11%	0.47%	1.51%
1 Month Performance	-7.40%	2.76%	9.14%	2.74%
1 Year Performance	-43.45%	19.24%	44.00%	21.07%

BioLargo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BLGO BioLargo	N/A	$0.10 -3.8%	N/A	-41.2%	$34.13M	$12.23M	N/A	30
ACNT Ascent Industries	0.5667 of 5 stars	$14.83 +0.5%	N/A	+25.8%	$133.62M	$74.94M	N/A	710	Positive News
ARQ ARQ	2.4791 of 5 stars	$2.28 -0.9%	$5.00 +119.3%	-68.2%	$99.57M	$120.34M	N/A	140	Earnings Report
NTIC Northern Technologies International	2.8407 of 5 stars	$8.08 -0.1%	N/A	+7.2%	$76.73M	$91.84M	N/A	200	Positive News
FSI Flexible Solutions International	2.5746 of 5 stars	$5.00 +1.0%	N/A	-32.8%	$63.74M	$39.34M	15.15	40	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BLGO) was last updated on 8/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioLargo (BLGO) Competitors

BLGO vs. ACNT, ARQ, NTIC, FSI, and AVD

How does BioLargo compare to Ascent Industries?

Summary

How does BioLargo compare to ARQ?

Summary

How does BioLargo compare to Northern Technologies International?

Summary

How does BioLargo compare to Flexible Solutions International?

Summary

How does BioLargo compare to American Vanguard?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLGO vs. The Competition

BioLargo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BioLargo (BLGO) Competitors

BLGO vs. ACNT, ARQ, NTIC, FSI, and AVD

How does BioLargo compare to Ascent Industries?

Which has more volatility and risk, BLGO or ACNT?

Does the media favor BLGO or ACNT?

Do insiders and institutionals believe in BLGO or ACNT?

Do analysts recommend BLGO or ACNT?

Is BLGO or ACNT more profitable?

Which has preferable earnings & valuation, BLGO or ACNT?

Summary

How does BioLargo compare to ARQ?

Do analysts prefer ARQ or BLGO?

Is ARQ or BLGO more profitable?

Do institutionals and insiders hold more shares of ARQ or BLGO?

Which has more volatility and risk, ARQ or BLGO?

Which has better earnings and valuation, ARQ or BLGO?

Does the media refer more to ARQ or BLGO?

Summary

How does BioLargo compare to Northern Technologies International?

Which has preferable valuation & earnings, NTIC or BLGO?

Is NTIC or BLGO more profitable?

Do insiders and institutionals hold more shares of NTIC or BLGO?

Which has more risk and volatility, NTIC or BLGO?

Do analysts recommend NTIC or BLGO?

Does the media prefer NTIC or BLGO?

Summary

How does BioLargo compare to Flexible Solutions International?

Do institutionals and insiders hold more shares of BLGO or FSI?

Does the media prefer BLGO or FSI?

Do analysts recommend BLGO or FSI?

Which has better earnings & valuation, BLGO or FSI?

Is BLGO or FSI more profitable?

Which has more volatility & risk, BLGO or FSI?

Summary

How does BioLargo compare to American Vanguard?

Do analysts rate BLGO or AVD?

Do insiders & institutionals believe in BLGO or AVD?

Is BLGO or AVD more profitable?

Which has more risk and volatility, BLGO or AVD?

Does the media favor BLGO or AVD?

Which has stronger earnings & valuation, BLGO or AVD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLGO vs. The Competition

BioLargo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools